Company / Current Liabilities per Share
Anika Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.52
FY2025
5-year range
$1.52 / $2.12
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.59 in FY2016 to $2.12 in FY2023.
Based on SEC 10-K filings.
1.52 in FY2025 with a 5-year CAGR of +6.0%.
Improved from $2.12 to $1.52 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -7.7%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 4.4% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.52 | -4.4% |
| FY2024 | $1.59 | -25.1% |
| FY2023 | $2.12 | +9.9% |
| FY2022 | $1.93 | -7.0% |
| FY2021 | $2.08 | +82.8% |
| FY2020 | $1.14 | -0.7% |
| FY2019 | $1.15 | +49.0% |
| FY2018 | $0.77 | -14.0% |
| FY2017 | $0.89 | +52.7% |
| FY2016 | $0.59 | -49.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026